The clinical implication of inhibiting platelet activation on chronic renal allograft dysfunction: A prospective cohort study

Transplantation Proceedings

Volumn 43, Issue 7, 2011, Pages 2596-2600

  Zhang, Y ^a   Zong, H T ^a   Yang, C C ^a   Zhang, X D ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD61 ANTIGEN; CD63 ANTIGEN; CYCLOSPORIN; DUAL SPECIFICITY PHOSPHATASE 2; PLATELET DERIVED GROWTH FACTOR BB; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROSPECTIVE STUDIES;

EID: 80052705763     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.047     Document Type: Article

References (17)

1. M.J. Gutiérrez, E. González, and A. Andrés Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction Transplant Proc 41 2009 2348
2. B. Höcker, and B. Tönshoff Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview Paediatr Drugs 11 2009 381
3. B.M. Shrestha, and J.L. Haylor Factors influencing long-term outcomes following renal transplantation: a review JNMA J Nepal Med Assoc 46 2007 136
4. R.K. Wali, and M.R. Weir Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function? Curr Opin Organ Transplant 13 2008 614
5. L.M. Birnbaum, M. Lipman, and S. Paraskevas Management of chronic allograft nephropathy: a systematic review Clin J Am Soc Nephrol 4 2009 860
6. W. Grotz, S. Siebig, and M. Olschewski Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation Transplantation 77 2004 1848
7. Y. Zhang, X.D. Zhang, and L.L. Ma Relationship between platelet activation and acute rejection after renal transplantation Transplant Proc 41 2009 1547
8. B. Najafian, and B.L. Kasiske Chronic allograft nephropathy Curr Opin Nephrol Hypertens 17 2008 149
9. C.N. Morrell, H. Sun, and A.M. Swaim Platelets an inflammatory force in transplantation Am J Transplant 7 2007 2447
10. C.N. Morrell, K. Murata, and A.M. Swaim In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody Circ Res 102 2008 777
11. Y. Zhang, D.L. Guan, and C.Q. Xia Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation Transplant Proc 37 2005 4208
12. M.R. Marwali, C.P. Hu, and B. Mohandas Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling J Pharmacol Exp Ther 322 2007 1324
13. A.F. Swaim, D.J. Field, and K. Fox-Talbot Platelets contribute to allograft rejection through glutamate receptor signaling J Immunol 185 2010 6999
14. J.C. Sill, J.A. Proper, and M.E. Johnson Reactive oxygen species and human platelet GP IIb/IIIa receptor activation Platelets 18 2007 613
15. Q. Yan, W. Sui, and S. Xie Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy Transpl Immunol 23 2010 1
16. A. Djamali, and M. Samaniego Fibrogenesis in kidney transplantation: potential targets for prevention and therapy Transplantation 88 2009 1149
17. H.Y. Yu, C.H. Liu, and Y.S. Chen Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement J Formos Med Assoc 104 2005 236